Literature DB >> 413767

The effect of volume on the distribution of substances instilled into the peritoneal cavity.

N Rosenshein, D Blake, P A McIntyre, T Parmley, T K Natarajan, J Dvornicky, E Nickoloff.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 413767     DOI： 10.1016/0090-8258(78)90010-0

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  12 in total

1.  Impact of laparotomy finding of significant intraabdominal adhesions on the surgically defined complete response rate to subsequent salvage intraperitoneal chemotherapy.

Authors:  M Markman; W Jones; J L Lewis; S Rubin; T Hakes; B Reichman; R Barakat; J Curtin; L Almadrones; W Hoskins
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Enhancing delivery of small molecule and cell-based therapies for ovarian cancer using advanced delivery strategies.

Authors:  Joanne O'Dwyer; Roisin E O'Cearbhaill; Robert Wylie; Saoirse O'Mahony; Michael O'Dwyer; Garry P Duffy; Eimear B Dolan
Journal:  Adv Ther (Weinh)       Date:  2020-08-16

3.  High volume intraperitoneal chemotherapy ("belly bath") for ovarian cancer. Pharmacologic basis and early results.

Authors:  R B Jones; C E Myers; A M Guarino; R L Dedrick; S M Hubbard; V T DeVita
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

4.  Adjuvant intraperitoneal 5-fluorouracil and intravenous leucovorin after colorectal cancer surgery: a randomized phase II placebo-controlled study.

Authors:  W Graf; J E Westlin; L Påhlman; B Glimelius
Journal:  Int J Colorectal Dis       Date:  1994-04       Impact factor: 2.571

5.  Pharmacokinetics and tissue distribution of intraperitoneal 5-fluorouracil with a novel carrier solution in rats.

Authors:  Zhi-Gang Wei; Guo-Xin Li; Xiang-Cheng Huang; Li Zhen; Jiang Yu; Hai-Jun Deng; Shan-Hua Qing; Ce Zhang
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

Review 6.  Treatment of malignant ascites.

Authors:  Michael Chung; Peter Kozuch
Journal:  Curr Treat Options Oncol       Date:  2008-09-06

Review 7.  Intracavitary chemotherapy for malignant disease confined to body cavities.

Authors:  M Markman
Journal:  West J Med       Date:  1985-03

8.  The intraperitoneal delivery of radiolabeled monoclonal antibodies: studies on the regional delivery advantage.

Authors:  R L Wahl; J Barrett; O Geatti; M Liebert; B S Wilson; S Fisher; J G Wagner
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

Review 9.  Intraperitoneal therapy in the management of ovarian carcinoma.

Authors:  M Markman; T Hakes; B Reichman; W Hoskins; S Rubin; W Jones; L Almadones; J L Lewis
Journal:  Yale J Biol Med       Date:  1989 Jul-Aug

Review 10.  Optimization of drug delivery systems for intraperitoneal therapy to extend the residence time of the chemotherapeutic agent.

Authors:  L De Smet; W Ceelen; J P Remon; C Vervaet
Journal:  ScientificWorldJournal       Date:  2013-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.